drugset / Trial / NCT05945147
Ketamine and Midazolam Infusions for CRPS: Feasibility Study
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will assess the feasibility of administering ketamine plus midazolam or midazolam alone, when infused over 5 days in an outpatient setting, to adults with complex regional pain syndrome (CRPS).
Timeline
- Start
- 2099-01-01
- Primary completion
- 2099-04-30
- Completion
- 2099-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.4 mg/kg | Intravenous |
| Subject | Midazolam | Small molecule | 0.04 mg/kg | Intravenous |